Filing Details
- Accession Number:
- 0001104659-16-099476
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-24 12:05:12
- Reporting Period:
- 2016-02-22
- Filing Date:
- 2016-02-24
- Accepted Time:
- 2016-02-24 12:05:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1628214 | Lisa Alderson | C/O Invitae Corporation 458 Brannan Street San Francisco CA 94107 | Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-02-22 | 7,500 | $3.42 | 31,819 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-02-22 | 7,500 | $7.64 | 24,319 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-02-22 | 7,500 | $0.00 | 7,500 | $3.42 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,833 | 2014-02-28 | No | 4 | M | Direct |
Footnotes
- Represents weighted average sale price. Actual sale prices ranged from $7.5 to $7.85.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- The option became exercisable as to 25% of the shares on February 28, 2015, and becomes exercisable as to 1/48th of the shares each full month thereafter.